{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:44:22Z","timestamp":1790811862957,"version":"4.1.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00124","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T16:18:34Z","timestamp":1583511514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":127,"title":["From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Tommaso","family":"Cassano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyasagar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw","family":"Orkisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Serviddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2174\/092986711794940888","article-title":"Cannabinoids: occurrence and medicinal chemistry","volume":"18","author":"Appendino","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jnr.23318","article-title":"5-S-cysteinyldopamine neurotoxicity: Influence on the expression of \u03b1-synuclein and ERp57 in cellular and animal models of Parkinson's disease","volume":"92","author":"Aureli","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2009.11.020","article-title":"Striatal 6-OHDA lesion in mice: investigating early neurochemical changes underlying Parkinson's disease","volume":"208","author":"Branchi","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4720532","article-title":"Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer's disease: in\u00a0vitro and in vivo evidence","volume":"2018","author":"Bronzuoli","year":"2018","journal-title":"Oxid. Med. Cell Longev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","article-title":"Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease","volume":"19","author":"Caspersen","year":"2005","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.09.021","article-title":"Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease","volume":"33","author":"Cassano","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1567205013666151218132725","article-title":"Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration","volume":"13","author":"Cassano","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00030","article-title":"Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target","volume":"11","author":"Cassano","year":"2017","journal-title":"Front. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","article-title":"GPR55: A therapeutic target for Parkinson's disease","volume":"125","author":"Celorrio","year":"2017","journal-title":"Neuropharmacology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.01.014","article-title":"Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol","volume":"139","author":"da Silva","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/bjp.2008.190","article-title":"Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes","volume":"154","author":"Dennis","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","volume":"325","author":"De Petrocellis","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B19","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/3-540-26573-2_5","article-title":"The biosynthesis, fate and pharmacological properties of endocannabinoids","volume":"168","author":"Di Marzo","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuropharm.2005.11.008","article-title":"Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells","volume":"50","author":"Drysdale","year":"2006","journal-title":"Neuropharmacology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-TH(1A) and TRPV1 receptor mechanisms","volume":"19","author":"Galaj","year":"2019","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/antiox7070093","article-title":"Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid Analogues","volume":"18","author":"Gallelli","year":"2018","journal-title":"Antioxid (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3416028","article-title":"Oxidative stress in aging brain: nutritional and pharmacological interventions for neurodegenerative disorders","volume":"2018","author":"Giudetti","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms19071992","article-title":"In vitro model of neuroinflammation: efficacy of cannabigerol, a non-psychoactive cannabinoid","volume":"19","author":"Gugliandolo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2119\/molmed.2014.00261","article-title":"Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis","volume":"21","author":"Hao","year":"2015","journal-title":"Mol. Med."},{"key":"B36","first-page":"579","article-title":"Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies","volume":"232","author":"Hillard","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-s","article-title":"The cannabinoid receptor: biochemical, anatomical and behavioral characterization","volume":"13","author":"Howlett","year":"1990","journal-title":"Trends Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1476-5381.2011.01364.x","article-title":"Endocannabinoid tone versus constitutive activity of cannabinoid receptors","volume":"163","author":"Howlett","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0006-8993(86)90902-9","article-title":"Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites","volume":"376","author":"Hoyer","year":"1986","journal-title":"Brain Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","article-title":"Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro","volume":"207","author":"Jenny","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/sj.mp.4000999","article-title":"Retrograde signaling at central synapses via endogenous cannabinoids","volume":"7","author":"Kano","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2008.10.001","article-title":"Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain","volume":"30","author":"Kunos","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.3390\/ijms18010026","article-title":"Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells","volume":"18","author":"Libro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nm1106-1241","article-title":"Alzheimer's APP mangles mitochondria","volume":"12","author":"Lin","year":"2006","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.bjp.0706418","article-title":"New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis","volume":"147","author":"Ligresti","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/bjp.2008.57","article-title":"The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum","volume":"154","author":"Ma","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2009.04.021","article-title":"Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation","volume":"51","author":"Magen","year":"2009","journal-title":"J. Hepatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nbd.2014.11.024","article-title":"Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"74","author":"Martinez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/j.1476-5381.2012.02019.x","article-title":"GPR18 in microglia: implications for the CNS and endocannabinoid system signalling","volume":"167","author":"McHugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0009-3084(00)00184-5","article-title":"A historical overview of chemical research on cannabinoids","volume":"108","author":"Mechoulam","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2013recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem. Biodivers."},{"key":"B62","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future Med. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/msj.20165","article-title":"Current treatment and recent clinical research in Alzheimer's disease","volume":"77","author":"Neugroschl","year":"2010","journal-title":"Mt Sinai J. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2009.03.010","article-title":"Time-dependent vascular actions of cannabidiol in the rat aorta","volume":"612","author":"O\u2019Sullivan","year":"2009","journal-title":"Eur J. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"O'Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O'Sullivan","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1691428","article-title":"Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer","volume":"2018","author":"Pellati","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl. J. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2016.12.046","article-title":"Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal","volume":"111","author":"Romano","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.amjopharm.2009.06.003","article-title":"Drug development for Alzheimer's disease: where are we now and where are we headed","volume":"7","author":"Sabbagh","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother"},{"key":"B81","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","article-title":"Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects","volume":"8","author":"Scuderi","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2174\/138161211796904740","article-title":"Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases","volume":"17","author":"Serviddio","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"B84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00223-006-0171-7","article-title":"Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors","volume":"80","author":"Scutt","year":"2007","journal-title":"Calcif. Tissue Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","volume":"168","author":"Szabo","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1124\/dmd.108.020909","article-title":"Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis","volume":"36","author":"Takeda","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"B87","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainres.2004.01.090","article-title":"The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat","volume":"1008","author":"Trabace","year":"2004","journal-title":"Brain Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/abbs\/gmx073","article-title":"Effects of cannabidiol interactions with Wnt\/\u03b2-catenin pathway and PPAR\u03b3 on oxidative stress and neuroinflammation in Alzheimer's disease","volume":"49","author":"Vall\u00e9e","year":"2017","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T16:18:37Z","timestamp":1583511517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":92,"alternative-id":["10.3389\/fphar.2020.00124"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00124","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"article-number":"124"}}